期刊文献+

喉鳞癌中P糖蛋白表达与细胞增殖、凋亡及预后的关系

Significance of apoptotic and proliferative indices and P-glycoprotein expression in laryngeal squamous cell carcinoma
原文传递
导出
摘要 目的探讨P糖蛋白在喉鳞癌组织中表达与肿瘤细胞的增殖、凋亡活性,及其临床病理特征与患者预后的关系。方法应用免疫组化技术检测86例患者喉鳞癌组织中P糖蛋白、Ki-67的表达,TUNEL法测定喉鳞癌细胞凋亡率。结果 P糖蛋白在喉鳞癌组织中的阳性表达率为39.5%(34/86),与喉鳞癌的临床分期、组织学分级、淋巴结转移及患者术后生存率有关(均P<0.05);P糖蛋白表达阳性组的肿瘤细胞凋亡率比阴性组低(P<0.05),而增殖率差异无统计学意义(P>0.05)。结论 P糖蛋白可能对喉鳞癌细胞的凋亡活性具有一定抑制作用;P糖蛋白阳性表达率对于评估喉鳞癌病程进展及预后具有一定价值。 Objective To explore the relationship of P-glycoprotein expression with the apoptotic index,proliferative index,clinicopathological characteristics,and their prognostic values in laryngeal squamous cell carcinoma(LSCC).Methods Samples from 86 patients with LSCC were analyzed for P-glycoprotein and Ki-67 expression with immunohistochemistry,and the apoptotic index with the TUNEL method.The association of P-glycoprotein expression with clinicopathological parameters,apoptotic and proliferative activities,and patients′ overall survival was subsequently analyzed.Results It was found that up-regulation of P-glycoprotein expression was associated with decreased apoptosis(P0.05) but not with the changes in proliferation(P0.05).Expression of P-glycoprotein was significantly related to the clinical stage,histological grading,lymph node metastasis and overall survival in LSCC(P0.05).Conclusion These results show that the overexpression of P-glycoprotein may abrogate the apoptosis of LSCC cells.Furthermore,the results demonstrate that P-glycoprotein is predictive of malignant progression and prognosis of LSCC.
出处 《山东大学耳鼻喉眼学报》 CAS 2011年第4期8-12,共5页 Journal of Otolaryngology and Ophthalmology of Shandong University
基金 上海市生物医药领域重点科技项目(09411951000) 上海市级医院临床科研资源共享平台(SHDC12007206)
关键词 喉肿瘤 P糖蛋白 凋亡 细胞增殖 预后 Laryngeal neoplasms P-glycoprotein Apoptosis Cell proliferation Prognosis
  • 相关文献

参考文献14

  • 1Hipfner D R, Cohen S M. Connecting proliferation and apoptosis in development and disease [ J ]. Nat Rev Mol Cell Biol 2004, 5-805-815.
  • 2Teppo H, Soini Y, Melkko J, et al. Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, prolifer- ation ( Ki-67 ) and angiogenesis [ J ]. APMIS, 2003, 111:451-457.
  • 3Mizutani T, Masuda M, Nakai E, et al. Genuine func- tions of P-glycoprotein ( ABCB1 ) [J]. Curr Drug Metab, 2008, 9:167-174.
  • 4Smyth M J, Krasovskis E, Sutton V R, et al. The drug efflux protein, P-glycoprotein, additionally protects drug- resistant tumor cells from multiple forms of caspase-de- pendent apoptosis[ J]. Proc Natl Acad Sci U S A,1998, 95:7024-7029.
  • 5Takanishi K, Miyazaki M, Ohtsuka M, et al. Inverse re- lationship between P-glycoprotein expression and its pro- liferative activity in hepatocellular carcinoma[ J ]. Oncol- ogy, 1997, 54:231-237.
  • 6Li L, Jiang A C, Dong P, et al. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol [ J ]. Ann Surg On- col, 2009, 16:1421-1428.
  • 7Colone M, Calcabrini A, Toccacieli L, et al. The multi- drug transporter P-glycoprotein: a mediator of melanoma invasion .9 [ J ]. J Invest Dermatol, 2008, 128:957-971.
  • 8Yakirevieh E, Sabo E, Naroditsky I, et al. Multidrug re- sistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas [ J ]. Gynecol On- col, 2006, 100:152-159.
  • 9Raspollini M R, Amunni G, Villanucci A, et al. In- creased cyclooxygenase-2 (COX-2) and P-glycoprotein- 170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carci- noma patients with low and high survival [ J ]. Int J Gyne- col Cancer, 2005, 15:255-260.
  • 10Ng I O Liu C L, Fan S T, et al. Expression of P-gly- coprotein in hepatoceUular carcinoma. A determinant of chemotherapy response [J]. Am J Clin Pathol, 2000,113:355-363.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部